Balancing Shareholder Returns, Retained Earnings, and Capital Investment
First written in FY2024. 4 of 6 entries say "Softened", first in 2026-05-15. Latest entry: FY2026.
Kohjin Bio moved to the "Worse" side of this theme in 2026, 3 years after the typical company in this theme (2023).
13 other companies' latest entry also says "Softened".
- FY2026SoftenedAnnual report
「Under the above policy, the dividend from surplus for the fiscal year is scheduled to be ¥10 per share.」
The basic policy of balancing shareholder returns with retained earnings continues, but the scheduled dividend has decreased from ¥24 per share in the previous fiscal year to ¥10. - FY2025RestatedAnnual report
「We regard returning profits to shareholders as one of management's key priorities. At the same time, we believe that maintaining a stable management base and strengthening retained earnings as a reserve for future business development are also important to enhancing corporate value.」
The company has reaffirmed its policy of balancing shareholder returns with retained earnings and capital investment. The dividend for the fiscal year ending March 2025 is scheduled to be ¥24 per share. - FY2024First statedAnnual report
「We regard returning profits to shareholders as one of management's key priorities. At the same time, we believe that maintaining a stable management base and strengthening retained earnings as a reserve for future business development are also important to enhancing corporate value.」
The dividend for the current fiscal year is ¥14 per share, and the policy is to allocate retained earnings to business development and capital investment in plant and equipment.